6598 — Applied BioCode Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Applied BioCode, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	424	848	646	831	605
Net Total Accounts Receivable
Net Total Receivables	24.1	49.5	67.8	70.8	51
Total Inventory
Total Other Current Assets
Total Current Assets	540	1,021	826	1,014	837
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	121	172	163	170	131
Net Intangible Assets
Other Long Term Assets
Total Assets	719	1,227	1,019	1,212	993
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	112	77.8	59.9	87.6	102
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	188	140	116	396	332
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	531	1,087	903	816	661
Total Liabilities & Shareholders' Equity	719	1,227	1,019	1,212	993
Total Common Shares Outstanding